KI
Kilitch Drugs (India) Limited
KILITCH.NS · NSE
₹180.95 +4.89% (+₹8.43)
1M -6.50%
Market Cap ₹6.06B
P/E Ratio 20.17x
Div. Yield -
ROE 11.90%
Bulios Fair Price
₹134.2
25.8% downside
Trenutna cena
₹180.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KILITCH.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
58 /100
Fair PEG 1.55x
P/E 20.17x
P/B 2.17x
Growth
100 /100
Growing Book val. growth 22.64%
EPS growth 39.46%
Rev. growth 19.04%
Profitability
48 /100
Moderate Op. margin 13.66%
Gross margin 39.01%
FCF margin 24.50%
Quality
46 /100
Average ROA 6.57%
ROIC 6.61%
Asset turnover 0.52x
Debt
83 /100
Low Int. coverage 8.06x
Debt/Equity 0.32x
Net debt/EBITDA 1.66x
Stability
70 /100
Stable EPS volatility 36.02%
Beta 0.36x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KILITCH.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mukund Prataprai Mehta
Employees
236
Headquarters
Mumbai